Company
Inotrem
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Inotrem has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses
Loading relationship preview